A novel cause for abnormal liver function tests in pregnancy and the puerperium: Non-alcoholic fatty liver disease

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 118, Issue 12, 2011, Pages 1532-1535

  Page, L M ^a   Girling, J C ^a  

^a WEST MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Abnormal liver function tests; non alcoholic fatty liver disease; pregnancy

Indexed keywords

ABNORMAL LABORATORY RESULT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; HUMAN; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MATERNAL CARE; NONALCOHOLIC FATTY LIVER; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; PUERPERIUM;

ADULT; FATTY LIVER; FEMALE; HUMANS; LIVER FUNCTION TESTS; PREGNANCY; PREGNANCY COMPLICATIONS; PUERPERAL DISORDERS; RETROSPECTIVE STUDIES;

EID: 84860391782     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2011.03070.x     Document Type: Article

References (13)

1. Day C,. Non-alcoholic fatty liver disease: current concepts and management strategies. Clin Med 2006; 6: 19.
2. Ch'ng C, Morgan M, Hainsworth I, Kingham J,. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002; 51: 876-80. (Pubitemid 35408612)
3. Lewis G,; The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers' Lives: Reviewing Maternal Deaths to Make Motherhood Safer-2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. Chichester: Wiley (for CEMACH), 2007.
4. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S,. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos Nutrition and Liver Study. Hepatology 2005; 42: 44.
5. Bhala N, Usherwood T, George J,. 10-Minute Consultation Non-alcoholic fatty liver disease. Br Med J 2009; 339: b2474.
6. Ratziu V, Bonyhay L, Di Martino V, Charlotte F, Cavallaro L, Sayegh-Tainturier M,. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002; 35: 1485.
7. Adams L, Lymp J, St Sauver J, Sanderson S, Lindor K, Feldstein A,. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-21. (Pubitemid 41002048)
8. Bugianesi E, Bellentani S, Bedogni G, Tiribelli C, Svegliati Baroni G, Croce L,. Clinical update on non-alcoholic fatty liver disease and steatohepatitis. Ann Hepatol 2008; 7: 157-60. (Pubitemid 351845528)
9. Argo C, Northup P, Al Osaimi A, Caldwell S,. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol 2009; 51: 371-9.
10. International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Brussels: IDF Publications, 2006.
11. Kiel D, Dodson E, Artal R, Boehmer T, Leet T,. Gestational weight gain and pregnancy outcomes in obese women-How much is enough? Obstet Gynecol 2007; 10: 752-8. (Pubitemid 47508736)
12. Blomberg M,. Maternal and neonatal outcomes among obese women With weight gain below the new Institute of Medicine recommendations. Obstet Gynecol 2011; 117: 1065-70.
13. Bellamy L, Casas J, Hingorani A, Williams D,. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009; 373: 1773-9.